Print

Protein Central to Cancer Stem Cell Formation Provides New Potential Target, University of Texas MD Anderson Cancer Center Study  
2/14/2013 7:33:04 AM

Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development. Additionally, the international team led by scientists at The University of Texas MD Anderson Cancer Center found the cancer drug sunitinib potentially has a new role in treating triple-negative, claudin-low breast cancer, a particularly resistant version of a type of cancer that is already difficult to treat.